Header Logo

Connection

Ekaterina Pivovarova to Humans

This is a "connection" page, showing publications Ekaterina Pivovarova has written about Humans.
Connection Strength

0.352
  1. Pivovarova E, Planas Garcia BY, Friedmann PD, Stopka TJ, Santelices C, Evans EA. Collaborating With Jails to Provide Community-based Medication for Opioid Use Disorder: Qualitative Perspectives From MOUD Treatment Providers. J Addict Med. 2025 Jan-Feb 01; 19(1):95-101.
    View in: PubMed
    Score: 0.036
  2. Andraka-Christou B, Viglione J, Ahmed F, Del Pozo B, Atkins DN, Clark MH, Totaram R, Pivovarova E. Factors affecting problem-solving court team decisions about medications for opioid use disorder. J Subst Use Addict Treat. 2025 Jan; 168:209525.
    View in: PubMed
    Score: 0.036
  3. Pivovarova E, Taxman FS, Boland AK, Smelson DA, Lemon SC, Friedmann PD. Facilitators and barriers to collaboration between drug courts and community-based medication for opioid use disorder providers. J Subst Use Addict Treat. 2023 04; 147:208950.
    View in: PubMed
    Score: 0.032
  4. Pivovarova E, Evans EA, Stopka TJ, Santelices C, Ferguson WJ, Friedmann PD. Legislatively mandated implementation of medications for opioid use disorders in jails: A qualitative study of clinical, correctional, and jail administrator perspectives. Drug Alcohol Depend. 2022 05 01; 234:109394.
    View in: PubMed
    Score: 0.030
  5. Christopher PP, Pridgen BE, Pivovarova E. Experiences of Court Clinicians Who Perform Civil Commitment Evaluations for Substance Use Disorders. J Am Acad Psychiatry Law. 2021 Jun; 49(2):187-193.
    View in: PubMed
    Score: 0.028
  6. Pivovarova E, Min HS, Friedmann PD. Impact of extended release naltrexone on health-related quality of life in individuals with legal involvement and opioid use disorders. Subst Abus. 2021; 42(4):618-624.
    View in: PubMed
    Score: 0.027
  7. Pivovarova E, Klitzman RL, Murray A, Stiles DF, Appelbaum PS, Lidz CW. How Single Institutional Review Boards Manage Their Own Conflicts of Interest: Findings From a National Interview Study. Acad Med. 2019 10; 94(10):1554-1560.
    View in: PubMed
    Score: 0.025
  8. Pivovarova E, Stein MD. In their own words: language preferences of individuals who use heroin. Addiction. 2019 10; 114(10):1785-1790.
    View in: PubMed
    Score: 0.025
  9. Pivovarova E, Tanaka G, Tang M, Bursztajn HJ, First MB. Is Helplessness Still Helpful in Diagnosing Posttraumatic Stress Disorder? J Nerv Ment Dis. 2016 Jan; 204(1):3-8.
    View in: PubMed
    Score: 0.020
  10. Lidz CW, Albert K, Appelbaum P, Dunn LB, Overton E, Pivovarova E. Why is therapeutic misconception so prevalent? Camb Q Healthc Ethics. 2015 Apr; 24(2):231-41.
    View in: PubMed
    Score: 0.019
  11. Stopka TJ, Rottapel R, Friedmann PD, Pivovarova E, Evans EA. Perceptions of extended-release buprenorphine among people who received medication for opioid use disorder in jail: a qualitative study. Addict Sci Clin Pract. 2024 Sep 12; 19(1):68.
    View in: PubMed
    Score: 0.009
  12. Evans EA, Pivovarova E, Senthilkumar R, Rottapel RE, Stopka TJ, Santelices C, Ferguson WJ, Friedmann PD. Diversion of medications to treat opioid use disorder: Qualitative findings from formerly incarcerated adults in Massachusetts. Int J Drug Policy. 2023 Dec; 122:104252.
    View in: PubMed
    Score: 0.008
  13. Matsumoto A, Santelices C, Evans EA, Pivovarova E, Stopka TJ, Ferguson WJ, Friedmann PD. Jail-based reentry programming to support continued treatment with medications for opioid use disorder: Qualitative perspectives and experiences among jail staff in Massachusetts. Int J Drug Policy. 2022 11; 109:103823.
    View in: PubMed
    Score: 0.008
  14. Stopka TJ, Rottapel RE, Ferguson WJ, Pivovarova E, Toro-Mejias LD, Friedmann PD, Evans EA. Medication for opioid use disorder treatment continuity post-release from jail: A qualitative study with community-based treatment providers. Int J Drug Policy. 2022 Dec; 110:103803.
    View in: PubMed
    Score: 0.008
  15. Evans EA, Pivovarova E, Stopka TJ, Santelices C, Ferguson WJ, Friedmann PD. Uncommon and preventable: Perceptions of diversion of medication for opioid use disorder in jail. J Subst Abuse Treat. 2022 07; 138:108746.
    View in: PubMed
    Score: 0.008
  16. Evans EA, Stopka TJ, Pivovarova E, Murphy SM, Taxman FS, Ferguson WJ, Bernson D, Santelices C, McCollister KE, Hoskinson R, Lincoln T, Friedmann PD. Massachusetts Justice Community Opioid Innovation Network (MassJCOIN). J Subst Abuse Treat. 2021 09; 128:108275.
    View in: PubMed
    Score: 0.007
  17. Murray A, Pivovarova E, Klitzman R, Stiles DF, Appelbaum P, Lidz CW. Reducing the Single IRB Burden: Streamlining Electronic IRB Systems. AJOB Empir Bioeth. 2021 Jan-Mar; 12(1):33-40.
    View in: PubMed
    Score: 0.007
  18. Klitzman R, Appelbaum PS, Murray A, Pivovarova E, Stiles DF, Lidz CW. When IRBs Say No to Participating in Research about Single IRBs. Ethics Hum Res. 2020 Jan; 42(1):36-40.
    View in: PubMed
    Score: 0.006
  19. Klitzman R, Pivovarova E, Murray A, Appelbaum PS, Stiles DF, Lidz CW. Local Knowledge and Single IRBs for Multisite Studies: Challenges and Solutions. Ethics Hum Res. 2019 Jan; 41(1):22-31.
    View in: PubMed
    Score: 0.006
  20. Lidz CW, Pivovarova E, Appelbaum P, Stiles DF, Murray A, Klitzman RL. Reliance agreements and single IRB review of multisite research: Concerns of IRB members and staff. AJOB Empir Bioeth. 2018 Jul-Sep; 9(3):164-172.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.